Health Care • Medical/Dental Instruments
$79.93 ▲ +1.31
(+1.67%)
MKT CAP: $30.16B • VOL: 5.92M
52W L $54 52W H $93
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$67
MEDIAN
$90
MEAN
$91
HIGH
$109
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE DXCM TAPE
DXCM // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $96.72 | $91.92 | 2025-02-14 | $72.74 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $100.71 | $94.32 | 2025-02-06 | $75.13 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $91.12 | $87.92 | 2025-01-29 | $76.73 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $81.53 | — | 2025-01-17 | $78.33 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $70.34 | $75.93 | 2025-01-09 | $71.14 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $95.12 | $83.13 | 2024-12-18 | $69.54 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $77.53 | $80.73 | 2024-12-04 | $74.33 | -4.3% | 48% | C |